Lung transplantation is a life-saving treatment for patients with end stage lung disease. The
imbalance between lung graft supply and recipients has been a serious issue and barrier to …

Primary graft dysfunction (PGD) is a form of acute lung injury that results from ischemia
reperfusion injury (IRI) and is the major cause of early posttransplant morbidity and mortality …

The number of lung transplantations is progressively increasing worldwide, providing new
challenges to interprofessional teams and the intensive care units. The outcome of lung …

Lung ischemia-reperfusion injury (LIRI) is associated with many diseases, including primary
graft dysfunction after lung transplantation, and has no specific and effective therapies …

From the aHarefield Hospital Royal Brompton and Harefield Hospitals, Imperial College
London, London, United Kingdom, Semmelweis University, Budapest, Hungary; bUniversity …

Background In lung transplantation, ischemia-reperfusion injury associated with
mitochondrial damage can lead to graft rejection. Intact, exogenous mitochondria provide a …

Primary graft dysfunction (PGD) is a major cause of morbidity and mortality after lung
transplantation. Ischemia–reperfusion injury (IRI) is a key event that contributes to PGD …

Background Primary graft dysfunction (PGD) after lung transplantation (LuTx) contributes
substantially to early postoperative morbidity. Both intraoperative transfusion of a large …

Sarcoidosis is a systemic inflammatory disease of unknown etiology and variable clinical
course. Pulmonary sarcoidosis is the most common presentation and accounts for most …

Background. Primary graft dysfunction, which is directly related to cold ischemia–reperfusion
(CI/R) injury, is a major obstacle in lung transplantation (LTx). Ferroptosis, a novel mode of …